Sanoksu Co., Ltd.
Announcement of release of general SARS coronavirus antigen test kit “BIOCREDIT Covid-19 Antigen Test Kit Nasal (general use)”
Sanoksu Co., Ltd. (Headquarters: Tokyo, hereinafter referred to as “Sanoksu”) has started handling “BIOCREDIT Covid-19 Antigen Test Kit Nasal (General Use)” (hereinafter referred to as this product). ……
As the sole distributor of the “BIOCREDIT Covid-19 Antigen Test Kit Nasal” in Japan, Sanox has prioritized the sale of medical antigen test kits. Regarding the abolition of administrative notifications related to special measures related to business operations”
(Administrative notification of the General Affairs Division, Pharmaceutical Pharmacy, Ministry of Health, Labor and Welfare, dated March 25, 2020), the “BIOCREDIT Covid-19 We have started handling the antigen test kit Nasal (general use), hereinafter referred to as “this product”. As a result, this product can be sold face-to-face by pharmacists at drugstores and online, and can be used as a self-check if you are concerned about your physical condition. As the sole distributor of the “BIOCREDIT Covid-19 Antigen Test Kit Nasal” in Japan, Sunox will support measures against the new coronavirus infection through a stable supply of this product. For inquiries regarding this matter, please contact us via our website
(https://www.sunocs.co.jp/contact/form/). ■About “BIOCREDIT Covid-19 Antigen Test Kit Nasal (General Use)”
[Table 2: https://prtimes.jp/data/corp/108408/table/4_1_b41a7e6bbeda16e552a5a0c1c87e6c50.jpg] *The image is an image.
[Image: https://prtimes.jp/i/108408/4/resize/d108408-4-d6f20480a46811c02756-0.jpg&s3=108408-4-a2bf45673921466fb5aeb935221d2cf5-3900×2826.jpg]
More details about this release:
https://prtimes.jp/main/html/rd/p/000000004.000108408.html